FDA OKs Medtronic's rechargeable neurostimulator
This article was originally published in Clinica
Executive Summary
Boosting competition in the emerging US market for pain-relieving implantable spinal cord stimulators systems that are rechargeable, Medtronic has launched its Restore device, after receiving FDA approval for the product.